News & Analysis on the Clinical Development and Manufacture of Large Molecule Drugs
Moderna announced today that it is expanding its pipeline of innovative vaccines with three new development programs based on the 'clinical success' of its infectious disease vaccine portfolio to date.
Indonesia's food and drug agency, BPOM, today granted emergency use authorization to Sinovac’s vaccine against COVID-19.
Codagenix’s intranasal COVID-19 vaccine has entered Phase 1 clinical trials: with the first volunteers dosed in the UK.
Sanofi will acquire Kymab, a clinical-stage biopharmaceutical company developing fully human monoclonal antibodies. The acquisition will give it global rights to KY1005, which has the potential to treat a range of immune-mediated diseases and...